These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
271 related articles for article (PubMed ID: 15047742)
41. Use of caveolin-1, thyroid transcription factor-1, and cytokeratins 7 and 20 in discriminating between primary and secondary pulmonary adenocarcinoma from breast or colonic origin. Tsao SC; Su YC; Wang SL; Chai CY Kaohsiung J Med Sci; 2007 Jul; 23(7):325-31. PubMed ID: 17606426 [TBL] [Abstract][Full Text] [Related]
42. Diagnostic utility of PAX8, TTF-1 and napsin A for discriminating metastatic carcinoma from primary adenocarcinoma of the lung. Ye J; Hameed O; Findeis-Hosey JJ; Fan L; Li F; McMahon LA; Yang Q; Wang HL; Xu H Biotech Histochem; 2012 Jan; 87(1):30-4. PubMed ID: 21838611 [TBL] [Abstract][Full Text] [Related]
43. Mucinous and nonmucinous bronchioloalveolar adenocarcinomas have distinct staining patterns with thyroid transcription factor and cytokeratin 20 antibodies. Goldstein NS; Thomas M Am J Clin Pathol; 2001 Sep; 116(3):319-25. PubMed ID: 11554157 [TBL] [Abstract][Full Text] [Related]
44. Variable sensitivity and specificity of TTF-1 antibodies in lung metastatic adenocarcinoma of colorectal origin. Compérat E; Zhang F; Perrotin C; Molina T; Magdeleinat P; Marmey B; Régnard JF; Audouin J; Camilleri-Broët S Mod Pathol; 2005 Oct; 18(10):1371-6. PubMed ID: 15861215 [TBL] [Abstract][Full Text] [Related]
45. TTF-1 and napsin A do not differentiate metastatic lung adenocarcinomas from primary esophageal adenocarcinomas: proposal of a novel staining panel. Aulakh KS; Chisholm CD; Smith DA; Speights VO Arch Pathol Lab Med; 2013 Aug; 137(8):1094-8. PubMed ID: 23899066 [TBL] [Abstract][Full Text] [Related]
46. TTF-1 expression in pulmonary adenocarcinomas. Yatabe Y; Mitsudomi T; Takahashi T Am J Surg Pathol; 2002 Jun; 26(6):767-73. PubMed ID: 12023581 [TBL] [Abstract][Full Text] [Related]
47. Utility of thyroid transcription factor-1 and cytokeratin 20 in identifying the origin of metastatic carcinomas of cervical lymph nodes. Roh MS; Hong SH J Korean Med Sci; 2002 Aug; 17(4):512-7. PubMed ID: 12172048 [TBL] [Abstract][Full Text] [Related]
48. The correlation between TTF-1 immunoreactivity and the occurrence of lymph node metastases in patients with lung cancer. Altaner S; Yoruk Y; Tokatli F; Koçak Z; Tosun B; Guresci S; Kutlu K Tumori; 2006; 92(4):323-6. PubMed ID: 17036524 [TBL] [Abstract][Full Text] [Related]
49. Value of thyroid transcription factor-1, E-cadherin, BG8, WT1, and CD44S immunostaining in distinguishing epithelial pleural mesothelioma from pulmonary and nonpulmonary adenocarcinoma. Ordóñez NG Am J Surg Pathol; 2000 Apr; 24(4):598-606. PubMed ID: 10757409 [TBL] [Abstract][Full Text] [Related]
50. [Diagnostic value of the monoclonal antibody to thyroid transcription factor -1(TTF-1) in CNS metastases. An immunohistochemical study of 65 cases]. Romeike BF; Feiden W Pathologe; 2002 Jul; 23(4):292-6. PubMed ID: 12185782 [TBL] [Abstract][Full Text] [Related]
51. Thyroid transcription factor-1 and cytokeratins 7 and 20 in pulmonary and breast carcinoma. Harlamert HA; Mira J; Bejarano PA; Baughman RP; Miller MA; Whitsett JA; Yassin R Acta Cytol; 1998; 42(6):1382-8. PubMed ID: 9850647 [TBL] [Abstract][Full Text] [Related]
52. Immunohistochemical Detection of Pax8 and Napsin A in Canine Thyroid Tumours: Comparison with Thyroglobulin, Calcitonin and Thyroid Transcription Factor 1. Ramos-Vara JA; Frank CB; DuSold D; Miller MA J Comp Pathol; 2016 Nov; 155(4):286-298. PubMed ID: 27567273 [TBL] [Abstract][Full Text] [Related]
53. Expression of thyroid transcription factor-1 in the spectrum of neuroendocrine cell lung proliferations with special interest in carcinoids. Sturm N; Rossi G; Lantuejoul S; Papotti M; Frachon S; Claraz C; Brichon PY; Brambilla C; Brambilla E Hum Pathol; 2002 Feb; 33(2):175-82. PubMed ID: 11957142 [TBL] [Abstract][Full Text] [Related]
54. Prognostic significance of thyroid transcription factor-1 expression in both early-stage conventional adenocarcinoma and bronchioloalveolar carcinoma of the lung. Saad RS; Liu YL; Han H; Landreneau RJ; Silverman JF Hum Pathol; 2004 Jan; 35(1):3-7. PubMed ID: 14745718 [TBL] [Abstract][Full Text] [Related]
55. Thyroid transcription factor-1 is a marker of lung and thyroid carcinomas. Ordóñez NG Adv Anat Pathol; 2000 Mar; 7(2):123-7. PubMed ID: 10721419 [TBL] [Abstract][Full Text] [Related]
57. Thyroid transcription factor-1 (TTF-1) expression in human lung carcinomas: its prognostic implication and relationship with wxpressions of p53 and Ki-67 proteins. Myong NH J Korean Med Sci; 2003 Aug; 18(4):494-500. PubMed ID: 12923324 [TBL] [Abstract][Full Text] [Related]
58. TTF-1 protein expression in pleural malignant mesotheliomas and adenocarcinomas of the lung. Di Loreto C; Puglisi F; Di Lauro V; Damante G; Beltrami CA Cancer Lett; 1998 Feb; 124(1):73-8. PubMed ID: 9500194 [TBL] [Abstract][Full Text] [Related]